Proteomics

Dataset Information

0

Proteomics analysis of DUX4-expressing myoblasts


ABSTRACT: DUX4 is a double homeodomain transcription factor whose misexpression in the muscle causes facioscapulohumeral muscular dystrophy (FSHD). The transcriptional activity of DUX4 has been extensively characterized, and is thought to be the primary driver of FSHD pathogenesis. Yet, DUX4 expression lowers the protein level of an RNA quality control factor, UPF1, without affecting its transcript level, hinting at post-transcriptional regulatory activity downstream of DUX4 expression. How extensive the post-transcriptional activity of DUX4 is, and how relevant it is to FSHD pathogenesis, is unknown. In order to gain insight into DUX4-induced post-transcriptional gene regulation, we measured transcript and protein levels in DUX4 expressing cells via RNA-seq and SILAC-based quantitative mass spectrometry, respectively. We show that DUX4 transcriptional targets are robustly translated, including those genes previously identified as potential FSHD biomarkers. However, comparing the overall pattern of gene expression changes for RNA versus protein reveals striking differences in the most highly activated pathways, with the former showing changes in RNA processing and splicing, and the latter affecting the humoral immune response, proteolysis and exocytosis, among other pathways. Consistent with a misregulation of exocytosis, fluorescence imaging shows fragmented golgi apparatus in DUX4-expressing cells. Of the genes that showed discordant RNA and protein expression levels, post-transcriptional buffering was particularly evident for genes involved in stress response and may explain why DUX4-expressing cells succumb to toxicity despite robust transcriptional activation of stress response genes. Moreover, several genes involved in RNA decay including UPF1, UPF3B, SMG6 and XRN1 showed downregulation at the protein level, which may explain the massive inhibition of RNA quality control in DUX4-expressing cells. These results highlight the importance of considering post-transcriptional gene regulation in DUX4-expressing cells in order to fully understand the FSHD disease process.

INSTRUMENT(S): Orbitrap Fusion, LTQ Orbitrap Elite

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Myoblast

DISEASE(S): Facioscapulohumeral Muscular Dystrophy

SUBMITTER: Philip Gafken  

LAB HEAD: Sujatha Jagannathan

PROVIDER: PXD010221 | Pride | 2019-01-21

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
SJ042415_051615_.pdResult Other
SJ042415_051615_31.raw Raw
SJ042415_051615_32.raw Raw
SJ042415_051615_33.raw Raw
SJ042415_051615_34.raw Raw
Items per page:
1 - 5 of 60
altmetric image

Publications

Quantitative proteomics reveals key roles for post-transcriptional gene regulation in the molecular pathology of facioscapulohumeral muscular dystrophy.

Jagannathan Sujatha S   Ogata Yuko Y   Gafken Philip R PR   Tapscott Stephen J SJ   Bradley Robert K RK  

eLife 20190115


DUX4 is a transcription factor whose misexpression in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). DUX4's transcriptional activity has been extensively characterized, but the DUX4-induced proteome remains undescribed. Here, we report concurrent measurement of RNA and protein levels in DUX4-expressing cells via RNA-seq and quantitative mass spectrometry. DUX4 transcriptional targets were robustly translated, confirming the likely clinical relevance of proposed FSHD biomar  ...[more]

Similar Datasets

2021-12-15 | PXD023993 | Pride
2023-04-11 | PXD036038 | Pride
2013-10-01 | E-GEOD-45883 | biostudies-arrayexpress
2012-01-03 | E-GEOD-33799 | biostudies-arrayexpress
2023-06-27 | PXD042374 | Pride
2014-07-03 | E-GEOD-56787 | biostudies-arrayexpress
2016-09-21 | GSE85461 | GEO
2014-03-19 | E-GEOD-51041 | biostudies-arrayexpress
2022-07-05 | MSV000089812 | MassIVE
2012-01-03 | E-GEOD-33838 | biostudies-arrayexpress